Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, March 1, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Ed Arce Reiterated (AUPH) at Strong Buy and Held Target at $13 on, Mar 1st, 2024
Ed Arce of HC Wainwright & Co., Reiterated "Aurinia Pharmaceuticals Inc." (AUPH) at Strong Buy and Held Target at $13 on, Mar 1st, 2024.
Ed has made no other calls on AUPH in the last 4 months.
There are 2 other peers that have a rating on AUPH. Out of the 2 peers that are also analyzing AUPH, 0 agree with Ed's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Ed
- Olivia Brayer of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $10 on, Friday, February 23rd, 2024
- Douglas Miehm of "RBC Capital" Maintained at Buy with Decreased Target to $8 on, Friday, February 16th, 2024
